Table 2.
Effect of PPTT on the levels of renal malondiadehyde (MDA), catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) in CTX-treated mice.
| Groups | Doses (mg/kg∙BW) |
MDA (nmol/mg prot) |
GSH-Px (U/mg prot) |
SOD (U/mg prot) |
CAT (U/mg prot) |
|---|---|---|---|---|---|
| NC | / | 3.37 ± 0.32 | 481.46 ± 35.28 | 901.05 ± 53.27 | 38.38 ± 2.80 |
| CP | / | 4.72 ± 0.71 ## | 346.88 ± 32.61 ## | 786.68 ± 75.34 ## | 22.01 ± 3.15 ## |
| PPTT-50 | 50 | 4.01 ± 0.47 #* | 336.70 ± 28.97 ## | 836.44 ± 77.59 # | 22.69 ± 2.71 ## |
| PPTT-100 | 100 | 3.83 ± 0.44 # | 385.57 ± 35.04 ##* | 841.13 ± 68.31 #* | 23.28 ± 2.25 ## |
| PPTT-200 | 200 | 3.68 ± 0.39 ** | 406.76 ± 34.08 #* | 881.84 ± 84.48 ** | 27.20 ± 2.32 ##* |
Note: Significant difference is represented with # and *, p < 0.05; extremely significant difference with ## and **, p < 0.01. In addition, ## and # stand for difference versus normal group; ** and * for difference versus the CP group. The symbol / denotes that the animals in this group were not treated with PPTT.